The characteristics and predictive role of lymphocyte subsets in COVID-19 patients

Objective: To investigate the characteristics and predictive roles of lymphocyte subsets in COVID-19 patients. Method: We evaluated lymphocyte subsets and other clinical features of COVID-19 patients, and analyzed their potential impacts on COVID-19 outcomes. Results: 1. Lymphocyte subset counts in the peripheral blood of patients with COVID-19 were significantly reduced, especially in patients with severe disease. 2. In patients with non-severe disease, the time from symptom onset to hospital admission was positively correlated with total T cell counts. 3. Among COVID-19 patients who did not reach the composite endpoint, lymphocyte subset counts were higher than in patients who had reached the composite endpoint. 4. The Kaplan-Meier survival curves showed significant differences in COVID-19 patients, classified by the levels of total, CD8(+), and CD4(+) T cells at admission. Conclusion: Our study showed that total, CD8(+), and CD4(+) T cell counts in patients with COVID-19 were significantly reduced, especially in patients with severe disease. Lower T lymphocyte subsets were significantly associated with a higher occurrence of composite endpoint events. These subsets may help identify patients with a high risk of composite endpoint events. (c) 2020 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.